In this special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jeffrey P. Kiplinger, Partner at Selling Science.
Your host, Raman Sehgal, discusses Jeff’s new book, Expert to Entrepreneur, on the podcast. As a previous guest, Jeff is a good friend of the show.
Jeff Kiplinger is a PhD chemist who, after leaving a scientific leadership role at Pfizer in 1998, transitioned to business leadership and an entrepreneurial track. In 2007 he founded Averica Discovery, an analytical drug development CDMO in the Boston area. With solid growth in a tough economy, Averica was an attractive target and was acquired by a Canadian lab services company. Jeff left in 2018 and wrote about the experience of changing focus from science to business in his new book, “Expert to Entrepreneur: How to Turn Your Hard-Won Expertise into a Thriving Business”, which made the Amazon Bestseller list in its first week.
Jeff is passionate about helping scientist entrepreneurs build their businesses. He’s a keynote speaker and coach, leads mastermind groups for scientific founders, and is a co-creator and partner in Selling Science, a consulting firm that helps companies grow their revenue by developing successful sales programs. He still lives in the New England area with his wife Katy, and spends most of his free time outdoors hiking and cycling.
Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!
Molecule to Market is sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.